Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sebo

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Infection and Immunity|October 1, 1995
Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cellsP Sebo, C Fayolle, O d'Andria, et al.
The Journal of Biological Chemistry|April 10, 1999
The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase is crucial for toxin function independently of its acylation statusT Basar, V Havlícek, S Bezousková, et al.
Revue Medicale Suisse|June 24, 2010
[Diabetes and research in primary care: how to improve the care of our patients?]A Rieder, D M Haller, P Sebo, et al.
Infection and Immunity|May 4, 1999
Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxinS J Lee, M C Gray, L Guo, et al.
Infection and Immunity|June 17, 2000
Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussisG Dadaglio, Z Moukrim, R Lo-Man, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virusM F Saron, C Fayolle, P Sebo, et al.
Journal of Mass Spectrometry : JMS|May 3, 2001
Mass spectrometric analysis of recombinant adenylate cyclase toxin from Bordetella pertussis strain 18323/pHSP9V Havlícek, L Higgins, W Chen, et al.
Infection and Immunity|December 22, 1999
Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sitesR Osicka, A Osicková, T Basar, et al.
FEMS Immunology and Medical Microbiology|October 28, 1999
In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitopeP Sebo, Z Moukrim, M Kalhous, et al.
Bone Marrow Transplantation|March 29, 2011
In vitro activation of CMV-specific human CD8(+) T cells by adenylate cyclase toxoids delivering pp65 epitopesJ Jelinek, I Adkins, Z Mikulkova, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Infection and Immunity|October 1, 1995
Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cellsP Sebo, C Fayolle, O d'Andria, et al.
The Journal of Biological Chemistry|April 10, 1999
The conserved lysine 860 in the additional fatty-acylation site of Bordetella pertussis adenylate cyclase is crucial for toxin function independently of its acylation statusT Basar, V Havlícek, S Bezousková, et al.
Revue Medicale Suisse|June 24, 2010
[Diabetes and research in primary care: how to improve the care of our patients?]A Rieder, D M Haller, P Sebo, et al.
Infection and Immunity|May 4, 1999
Epitope mapping of monoclonal antibodies against Bordetella pertussis adenylate cyclase toxinS J Lee, M C Gray, L Guo, et al.
Infection and Immunity|June 17, 2000
Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussisG Dadaglio, Z Moukrim, R Lo-Man, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virusM F Saron, C Fayolle, P Sebo, et al.
Journal of Mass Spectrometry : JMS|May 3, 2001
Mass spectrometric analysis of recombinant adenylate cyclase toxin from Bordetella pertussis strain 18323/pHSP9V Havlícek, L Higgins, W Chen, et al.
Infection and Immunity|December 22, 1999
Delivery of CD8(+) T-cell epitopes into major histocompatibility complex class I antigen presentation pathway by Bordetella pertussis adenylate cyclase: delineation of cell invasive structures and permissive insertion sitesR Osicka, A Osicková, T Basar, et al.
FEMS Immunology and Medical Microbiology|October 28, 1999
In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying multiple copies of a viral CD8(+) T-cell epitopeP Sebo, Z Moukrim, M Kalhous, et al.
Bone Marrow Transplantation|March 29, 2011
In vitro activation of CMV-specific human CD8(+) T cells by adenylate cyclase toxoids delivering pp65 epitopesJ Jelinek, I Adkins, Z Mikulkova, et al.
Pageof 4